Prevalence of Glaucoma in the Israeli Arab Population

Glaucoma Clinical Trial

Official title:

Glaucoma Prevalence in the Israeli Arab Population

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT01546740
• Other study ID #: ZIV-0060-11
• Status: Recruiting
• Phase: N/A
• First received: March 1, 2012
• Last updated: March 6, 2012
• Start date: January 2012
• Est. completion date: May 2012

Study information

• Verified date: March 2012
• Source: Ziv Hospital
• Contact: Joseph Pikkel, M.D
• Phone: +972508434206
• Email: pikel.y[@]ziv.health.gov.il
• Is FDA regulated: No
• Health authority: Israel: Ministry of Health
• Study type: Observational

Clinical Trial Summary

there is a variety of glaucoma prevalence within different populations. this study examine the prevalence of glaucoma in the Arab population in Israel' as well as the demographic variables and the compliance to treatment in the population.

Description:

from Medical records of primary care clinic in the city of Tira. the patients are recruited, all glaucoma patients are above age of 20 years. they must suffer from CDR >= 0.5 with/without asymmetry with the other eye. or they suffer from glaucomatous damage to the visual fields.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 15000
• Est. completion date: May 2012
• Est. primary completion date: April 2012
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 20 Years and older

Eligibility

Inclusion Criteria:

• Cup-to-disk ratio (CDR) > 0.5 with asymmetry between the eyes

• Intraocular pressure (IOP) > 23 mm Hg

• Damage to the field of vision

• Age- above 20 Yrs. old

Exclusion Criteria:

Study Design

Observational Model: Ecologic or Community, Time Perspective: Retrospective

Related Conditions & MeSH terms

• Glaucoma

Locations

Country	Name	City	State
Israel	Ziv Medical Center	Safed

Sponsors (1)

Lead Sponsor	Collaborator
Ziv Hospital

Country where clinical trial is conducted

Israel,